About Suturion

It all started with a curious surgeon that encountered a clinical problem in abdominal wall closure and decided to do something about it. During practice surgeon Gabriel Börner often encountered complications after open abdominal surgery.

This experience, together with a growing body of scientific evidence and research showing that a evidence-based surgical technique can reduce patient complications, planted an idea of a device that could help surgeons prevent hernias instead of repairing them.

Suturion AB was founded in 2018 by Gabriel Börner, medtech engineer Mats O. Christensson and LU Holding AB. Suturion have during the last years filed several patent applications, performed extensive market analysis and pre-clinical research. Gabriel Börner is a frequent speaker at medical congresses and travels the world presenting his scientific research and findings. During 2022 Suturion will start a clinical trial which is an important step toward the regulatory pathway for CE and FDA approval.